Addition of hyaluronic acid improves cellular infiltration and promotes early-stage chondrogenesis in a collagen-based scaffold for cartilage tissue engineering

Journal of the Mechanical Behavior of Biomedical Materials

Volumn 11, Issue , 2012, Pages 41-52

  Matsiko, Amos ^a,b   Levingstone, Tanya J ^a,b   O'Brien, Fergal J ^a,b   Gleeson, John P ^a,b  

^a ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^b TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Chondrogenesis; Chondroitin sulphate; Collagen; Glycosaminoglycan; Hyaluronic acid; Scaffold

Indexed keywords

BIOFUNCTIONALITY; CARTILAGE TISSUE ENGINEERING; CARTILAGE TISSUES; CELLULAR INFILTRATION; CHONDROGENESIS; CHONDROITIN SULPHATE; COLLAGEN-BASED SCAFFOLDS; GLYCOSAMINOGLYCANS; HYALURONIC ACIDS; IN-VITRO; MEAN PORE SIZE; MESENCHYMAL STEM CELL; MORPHOLOGICAL CHARACTERISTIC; MORPHOLOGICAL PROPERTIES; TISSUE ENGINEERING APPLICATIONS; TYPE II;

CARTILAGE; CELL CULTURE; COLLAGEN; FLOWCHARTING; GENE EXPRESSION; MECHANICAL PROPERTIES; ORGANIC ACIDS; SCAFFOLDS; TISSUE;

SCAFFOLDS (BIOLOGY);

ASCORBIC ACID; CHONDROITIN SULFATE; COLLAGEN; COLLAGEN TYPE 1; COLLAGEN TYPE 2; DEXAMETHASONE; DNA; GLYCOSAMINOGLYCAN; HYALURONIC ACID; INSULIN; MESSENGER RNA; PROLINE; PYRUVATE SODIUM; TRANSCRIPTION FACTOR SOX9; TRANSFERRIN; TRANSFORMING GROWTH FACTOR BETA3;

ANIMAL CELL; ARTICLE; ARTICULAR CARTILAGE; CARTILAGE; CELL CULTURE; CELL DENSITY; CELL MIGRATION; CHONDROGENESIS; FEMUR; GENE EXPRESSION; HISTOLOGY; IN VITRO STUDY; MESENCHYMAL STEM CELL; MICROSCOPY; MORPHOLOGY; NONHUMAN; OSTEOARTHRITIS; PRIORITY JOURNAL; RAT; SULFATION; SYNTHESIS; TIBIA; TISSUE ENGINEERING;

ABSORPTION; ANIMALS; CARTILAGE; CELL COUNT; CHONDROGENESIS; CHONDROITIN SULFATES; COLLAGEN; COMPRESSIVE STRENGTH; GENE EXPRESSION REGULATION; HYALURONIC ACID; POROSITY; RATS; RATS, WISTAR; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPERATURE; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 84861707845     PISSN: 17516161     EISSN: 18780180     Source Type: Journal    
DOI: 10.1016/j.jmbbm.2011.11.012     Document Type: Article

References (60)

1. Aigner T., Stove J. Collagens-major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair. Adv. Drug Delivery Rev. 2003, 55:1569-1593.
2. Alhag M., Farrell E., Toner M., Claffey N., Lee T., O'Brien F. Evaluation of early healing events around mesenchymal stem cell-seeded collagen-glycosaminoglycan scaffold. An experimental study in Wistar rats. Oral. Maxillofac. Surg. 2011, 15:31-39.
3. Banu N., Tsuchiya T. Markedly different effects of hyaluronic acid and chondroitin sulfate-A on the differentiation of human articular chondrocytes in micromass and 3-D honeycomb rotation cultures. J. Biomed. Mater. Res. Part A 2007, 80A:257-267.
4. Bernstein P., Dong M., Corbeil D., Gelinsky M., Günther K.-P., Fickert S. Pellet culture elicits superior chondrogenic redifferentiation than alginate-based systems. Biotechnol. Prog. 2009, 25:1146-1152.
5. Bosnakovski D., Mizuno M., Kim G., Takagi S., Okumura M., Fujinaga T. Chondrogenic differentiation of bovine bone marrow mesenchymal stem cells (MSCs) in different hydrogels: influence of collagen type II extracellular matrix on MSC chondrogenesis. Biotechnol. Bioeng. 2006, 93:1152-1163.
6. Buckwalter J.A. Chondral and osteochondral injuries: mechanisms of injury and repair responses. Oper. Tech. Orthop. 1997, 7(4):263-269.
7. Buma P., Pieper J.S., van Tienen T., van Susante J.L.C., van der Kraan P.M., Veerkamp J.H., van den Berg W.B., Veth R.P.H., van Kuppevelt T.H. Cross-linked type I and type II collagenous matrices for the repair of full-thickness articular cartilage defects-a study in rabbits. Biomaterials 2003, 24:3255-3263.
8. Byrne E., Farrell E., McMahon L., Haugh M., O'Brien F., Campbell V., Prendergast P., O'Connell B. Gene expression by marrow stromal cells in a porous collagen-glycosaminoglycan scaffold is affected by pore size and mechanical stimulation. J. Mater. Sci. Mater. Med. 2008, 19:3455-3463.
9. Cascio B.M., Sharma B. The future of cartilage repair. Oper. Techn. Sport Med. 2008, 16:221-224.
10. Chamberlain L.J., Yannas I.V., Hsu H.P., Strichartz G., Spector M. Collagen-GAG substrate enhances the quality of nerve regeneration through collagen tubes up to level of autograft. Exp. Neurol. 1998, 154:315-329.
11. Chang C.-H., Lin H.-Y., Fang H.-W., Loo S.-T., Hung S.-C., Ho Y.-C., Chen C.-C., Lin F.-H., Liu H.-C. Chondrogenesis from immortalized human mesenchymal stem cells: comparison between collagen gel and pellet culture methods. Artif. Organs 2008, 32:561-566.
12. Chen W.Y.J., Abatangelo G. Functions of hyaluronan in wound repair. Wound Repair. Regen. 1999, 7:79-89.
13. Chung C., Burdick J.A. Influence of three-dimensional hyaluronic acid microenvironments on mesenchymal stem cell chondrogenesis. Tissue Eng. Part A 2008, 15:243-254.
14. Correia C.R., Moreira-Teixeira L.S., Moroni L., Reis R.L., van Blitterswijk C.A., Karperien M., Mano J.F. Chitosan scaffolds containing hyaluronic acid for cartilage tissue engineering. Tissue Eng. Part C Methods 2011, 17(7):717-730.
15. Culliford D.J., Maskell J., Beard D.J., Murray D.W., Price A.J., Arden N.K. Temporal trends in hip and knee replacement in the United Kingdom 1991 TO 2006. J. Bone Joint Surg. Br. 2010, 92B:130-135.
16. Dieppe P.A., Lohmander L.S. Pathogenesis and management of pain in osteoarthritis. Lancet 2005, 365:965-973.
17. Discher D.E., Janmey P., Wang Y.-l. Tissue cells feel and respond to the stiffness of their substrate. Science 2005, 310:1139-1143.
18. Duffy G.P., McFadden T.M., Byrne E.M., Gill S.L., Farrell E., O'Brien F.J. Towards in vitro vascularisation of collagen-GAG scaffolds. Eur. Cells Mater. 2011, 21:15-30.
19. Dussault A.-A., Pouliot M. Rapid and simple comparison of messenger rna levels using real-time PCR. Biol. Proced. Online 2006, 8:1-10.
20. Fan H., Zhang C., Li J., Bi L., Qin L., Wu H., Hu Y. Gelatin microspheres containing TGF-β3 enhance the chondrogenesis of mesenchymal stem cells in modified pellet culture. Biomacromolecules 2008, 9:927-934.
21. Farrell E., O'Brien F.J., Doyle P., Fischer J., Yannas I., Harley B.A., O'Connell B., Prendergast P.J., Campbell V.A. A collagen-glycosaminoglycan scaffold supports adult rat mesenchymal stem cell differentiation along osteogenic and chondrogenic routes. Tissue Eng. 2006, 12:459-468.
22. Friedl P., Bröcker E.B. The biology of cell locomotion within three-dimensional extracellular matrix. Cell. Mol. Life Sci. 2000, 57:41-64.
23. Getgood A., Bhullar T.P.S., Rushton N. Current concepts in articular cartilage repair. Orthop. Trauma 2009, 23(3):189-200.
24. Gobbi A., Kon E., Berruto M., Francisco R., Filardo G., Marcacci M. Patellofemoral full-thickness chondral defects treated with hyalograft-C. Am. J. Sports Med. 2006, 34:1763-1773.
25. Goldring M.B., Tsuchimochi K., Ijiri K. The control of chondrogenesis. J. Cell. Biochem. 2006, 97:33-44.
26. Gross A., Kim W., Las Heras F., Backstein D., Safir O., Pritzker K. Fresh osteochondral allografts for posttraumatic knee defects: long-term followup. Clin. Orthop. Relate. Res. 2008, 466:1863-1870.
27. Harley B.A., Leung J.H., Silva E.C.C.M., Gibson L.J. Mechanical characterization of collagen-glycosaminoglycan scaffolds. Acta Biomater. 2007, 3:463-474.
28. Haugh M.G., Murphy C.M., O'Brien F.J. Novel freeze-drying methods to produce a range of collagen-glycosaminoglycan scaffolds with tailored mean pore sizes. Tissue Eng. Part C Methods 2010, 16(5):887-894.
29. Hsu W.-C., Spilker M.H., Yannas I.V., Rubin P.A.D. Inhibition of conjunctival scarring and contraction by a porous collagen-glycosaminoglycan implant. Invest. Ophthalmol. Vis. Sci. 2000, 41(9):2404-2411.
30. Jenner J.M.G.T., van Eijk F., Saris D.B.F., Willems W.J., Dhert W.J.A., Creemers L.B. Effect of transforming growth factor-beta and growth differentiation factor-5 on proliferation and matrix production by human bone marrow stromal cells cultured on braided poly lactic-co-glycolic acid scaffolds for ligament tissue engineering. Tissue Eng. 2007, 13:1573-1582.
31. Karamichos D., Skinner J., Brown R., Mudera V. Matrix stiffness and serum concentration effects matrix remodelling and ECM regulatory genes of human bone marrow stem cells. J. Tissue Eng. Regen. Med. 2008, 2(2-3):97-105.
32. Knudson C.B. Hyaluronan and CD44: strategic players for cell-matrix interactions during chondrogenesis and matrix assembly. Birth Defects Res. Part C 2003, 69:174-196.
33. Knudson C.B., Knudson W. Hyaluronan and CD44: modulators of chondrocyte metabolism. Clin. Orthop. Relate. Res. 2004, 427:S152-S162.
34. Lawrence R.C., Felson D.T., Helmick C.G., Arnold L.M., Choi H., Deyo R.A., Gabriel S., Hirsch R., Hochberg M.C., Hunder G.G., Jordan J.M., Katz J.N., Kremers H.M., Wolfe F., National Arthritis Data W. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: part II. Arthritis Rheum. 2008, 58:26-35.
35. Lee H.J., Yu C., Chansakul T., Hwang N.S., Varghese S., Yu S.M., Elisseeff J.H. Enhanced chondrogenesis of mesenchymal stem cells in collagen mimetic peptide-mediated microenvironment. Tissue Eng. Part A 2008, 14:1843-1851.
36. Li W.-J., Tuli R., Okafor C., Derfoul A., Danielson K.G., Hall D.J., Tuan R.S. A three-dimensional nanofibrous scaffold for cartilage tissue engineering using human mesenchymal stem cells. Biomaterials 2005, 26:599-609.
37. Lisignoli G., Cristino S., Piacentini A., Toneguzzi S., Grassi F., Cavallo C., Zini N., Solimando L., Mario Maraldi N., Facchini A. Cellular and molecular events during chondrogenesis of human mesenchymal stromal cells grown in a three-dimensional hyaluronan based scaffold. Biomaterials 2005, 26:5677-5686.
38. Louie L.K., Yannas I.V., Hsu H.P., Spector M. Healing of tendon defects implanted with a porous collagen-GAG matrix: histological evaluation. Tissue Eng. 1997, 3:187-195.
39. Lyons F.G., Al-Munajjed A.A., Kieran S.M., Toner M.E., Murphy C.M., Duffy G.P., O'Brien F.J. The healing of bony defects by cell-free collagen-based scaffolds compared to stem cell-seeded tissue engineered constructs. Biomaterials 2010, 31:9232-9243.
40. Miot S., Woodfield T., Daniels A.U., Suetterlin R., Peterschmitt I., Heberer M., van Blitterswijk C.A., Riesle J., Martin I. Effects of scaffold composition and architecture on human nasal chondrocyte redifferentiation and cartilaginous matrix deposition. Biomaterials 2005, 26:2479-2489.
41. Murphy C.M., Haugh M.G., O'Brien F.J. The effect of mean pore size on cell attachment, proliferation and migration in collagen-glycosaminoglycan scaffolds for bone tissue engineering. Biomaterials 2010, 31:461-466.
42. Nehrer S., Domayer S., Dorotka R., Schatz K., Bindreiter U., Kotz R. Three-year clinical outcome after chondrocyte transplantation using a hyaluronan matrix for cartilage repair. Eur. J. Radiol. 2006, 57:3-8.
43. Newman A.P. Articular cartilage repair. Am. J. Sports Med. 1998, 26:309-324.
44. O'Brien F.J., Harley B.A., Yannas I.V., Gibson L. Influence of freezing rate on pore structure in freeze-dried collagen-GAG scaffolds. Biomaterials 2004, 25:1077-1086.
45. O'Brien F.J., Harley B.A., Yannas I.V., Gibson L.J. The effect of pore size on cell adhesion in collagen-GAG scaffolds. Biomaterials 2005, 26:433-441.
46. Park K., Cho K.-J., Kim J.-J., Kim I.-H., Han D.K. Functional PLGA scaffolds for chondrogenesis of bone-marrow-derived mesenchymal stem cells. Macromol. Biosci. 2009, 9:221-229.
47. Pfeiffer E., Vickers S.M., Frank E., Grodzinsky A.J., Spector M. The effects of glycosaminoglycan content on the compressive modulus of cartilage engineered in type II collagen scaffolds. Osteoarthr. Cartilage 2008, 16:1237-1244.
48. Pieper J.S., van Wachem P.B., van Luyn M.J.A., Brouwer L.A., Hafmans T., Veerkamp J.H., van Kuppevelt T.H. Attachment of glycosaminoglycans to collagenous matrices modulates the tissue response in rats. Biomaterials 2000, 21:1689-1699.
49. Temenoff J.S., Mikos A.G. Review: tissue engineering for regeneration of articular cartilage. Biomaterials 2000, 21:431-440.
50. Tierney C.M., Jaasma M.J., O'Brien F.J. Osteoblast activity on collagen-GAG scaffolds is affected by collagen and GAG concentrations. J. Biomed. Mater. Res. Part A 2009, 91A:92-101.
51. Toole B.P. Hyaluronan in morphogenesis. Semin. Cell Dev. Biol. 2001, 12:79-87.
52. Tse J.R., Engler A.J. Stiffness gradients mimicking tissue variation regulate mesenchymal stem cell fate. PLoS One 2011, 6:e15978.
53. Turley E.A., Austen L., Moore D., Hoare K. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion. Exp. Cell Res. 1993, 207:277-282.
54. van Susante J.L.C., Pieper J., Buma P., van Kuppevelt T.H., van Beuningen H., van der Kraan P.M., Veerkamp J.H., van den Berg W.B., Veth R.P.H. Linkage of chondroitin-sulfate to type I collagen scaffolds stimulates the bioactivity of seeded chondrocytes in vitro. Biomaterials 2001, 22:2359-2369.
55. Vickers S.M., Gotterbarm T., Spector M. Cross-linking affects cellular condensation and chondrogenesis in type II collagen-GAG scaffolds seeded with bone marrow-derived mesenchymal stem cells. J. Orthop. Res. 2010, 28:1184-1192.
56. Welsch G.H., Mamisch T.C., Zak L., Blanke M., Olk A., Marlovits S., Trattnig S. Evaluation of cartilage repair tissue after matrix-associated autologous chondrocyte transplantation using a hyaluronic-based or a collagen-based scaffold with morphological MOCART scoring and biochemical T2 mapping. Am. J. Sports Med. 2010, 38:934-942.
57. Wu C.-H., Ko C.-S., Huang J.-W., Huang H.-J., Chu I.M. Effects of exogenous glycosaminoglycans on human chondrocytes cultivated on type II collagen scaffolds. J. Mater. Sci. Mater. Med. 2010, 21:725-729.
58. Yannas I.V., Burke J.F. Design of an artificial skin. I. Basic design principles. J. Biomed. Mater. Res. 1980, 14:65-81.
59. Zhang L., Su P., Xu C., Yang J., Yu W., Huang D. Chondrogenic differentiation of human mesenchymal stem cells: a comparison between micromass and pellet culture systems. Biotechnol. Lett. 2010, 32:1339-1346.
60. Zhu H., Mitsuhashi N., Klein A., Barsky L.W., Weinberg K., Barr M.L., Demetriou A., Wu G.D. The role of the hyaluronan receptor CD44 in mesenchymal stem cell migration in the extracellular matrix. Stem Cells 2006, 24:928-935.